EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
Grupo de Ativistas em Tratamentos (GAT), Lisboa, Portugal.
Euro Surveill. 2020 Nov;25(47). doi: 10.2807/1560-7917.ES.2020.25.47.2001943.
We present preliminary results of a coronavirus disease (COVID-19) impact assessment on testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region. We analyse 98 responses from secondary care (n = 36), community testing sites (n = 52) and national level (n = 10). Compared to pre-COVID-19, 95% of respondents report decreased testing volumes during March-May and 58% during June-August 2020. Reasons for decreases and mitigation measures were analysed.
我们呈现了一项关于世界卫生组织欧洲区域内冠状病毒病（COVID-19）对艾滋病毒、病毒性肝炎和性传播感染检测影响评估的初步结果。我们分析了来自二级保健（n=36）、社区检测点（n=52）和国家层面（n=10）的 98 份答复。与 COVID-19 之前相比，95%的答复者报告 2020 年 3 月至 5 月期间检测量减少，58%的答复者报告 6 月至 8 月期间检测量减少。分析了减少的原因和缓解措施。
Zotero 插件